SLC27A2 Antikörper (AA 346-405)

Produktnummer ABIN1724864

Produktdetails anti-SLC27A2 Antikörper

Target: SLC27A2 (Solute Carrier Family 27 (Fatty Acid Transporter), Member 2 (SLC27A2))

Bindungsspezifität: AA 346-405

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser SLC27A2 Antikörper ist unkonjugiert

Applikation: ELISA, Western Blotting (WB), Immunohistochemistry (IHC)

Aufreinigung: purified

Immunogen: Purified recombinant fragment of human SLC27A2 (AA: 346-405) expressed in E. coli.

Klon: 6B3A9

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: ELISA: 1:10000, WB: 1:500 - 1:2000, IHC: 1:200 - 1:1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified antibody in PBS with 0.05 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: 4°C, -20°C for long term storage

Referenzen für anti-SLC27A2 Antikörper (ABIN1724864)

Mishima, Miner, Morizane, Stahl, Sadovsky: "The expression and function of fatty acid transport protein-2 and -4 in the murine placenta." in: PLoS ONE, Vol. 6, Issue 10, pp. e25865, (2011) (PubMed).

Campa, Hüsing, Chang-Claude, Dostal, Boeing, Kröger, Tjønneland, Roswall, Overvad, Dahm, Rodríguez, Sala, Pérez, Larrañaga, Chirlaque, Ardanaz, Khaw, Wareham, Allen, Travis, Trichopoulou, Naska et al.: "Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC). ..." in: European journal of cancer (Oxford, England : 1990), Vol. 47, Issue 3, pp. 420-7, (2011) (PubMed).

Details zu SLC27A2

Target: SLC27A2 (Solute Carrier Family 27 (Fatty Acid Transporter), Member 2 (SLC27A2))

Andere Bezeichnung: SLC27A2 (SLC27A2 Produkte)

Synonyme: vlcs antikoerper, fatp2 antikoerper, vlacs antikoerper, acsvl1 antikoerper, facvl1 antikoerper, im:7139614 antikoerper, slc27a2 antikoerper, wu:fb99g05 antikoerper, zgc:112376 antikoerper, ACSVL1 antikoerper, FACVL1 antikoerper, HsT17226 antikoerper, hFACVL1 antikoerper, FATP2 antikoerper, VLCS antikoerper, Vlac antikoerper, Vlacs antikoerper, VLACS antikoerper, solute carrier family 27 (fatty acid transporter), member 2 L homeolog antikoerper, solute carrier family 27 member 2 antikoerper, solute carrier family 27 (fatty acid transporter), member 2a antikoerper, solute carrier family 27 (fatty acid transporter), member 2 antikoerper, slc27a2.L antikoerper, SLC27A2 antikoerper, slc27a2a antikoerper, slc27a2 antikoerper, Slc27a2 antikoerper

Hintergrund:

Description: The protein encoded by this gene is an isozyme of long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. This isozyme activates long-chain, branched-chain and very-long-chain fatty acids containing 22 or more carbons to their CoA derivatives. It is expressed primarily in liver and kidney, and is present in both endoplasmic reticulum and peroxisomes, but not in mitochondria. Its decreased peroxisomal enzyme activity is in part responsible for the biochemical pathology in X-linked adrenoleukodystrophy. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. , ,

Aliases: VLCS, FATP2, VLACS, ACSVL1, FACVL1, hFACVL1, HsT17226

Molekulargewicht: 70.3 kDa

Gen-ID: 11001

HGNC: 11001

Pathways: Monocarboxylic Acid Catabolic Process, SARS-CoV-2 Protein Interaktom